Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Daily Dosing)

NCT00048516 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
68
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Abbott